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Summary
Hyperglycemia-induced mitochondrial dysfunction contributes to sensory neuron pathology in
diabetic neuropathy. Although Schwann cells (SCs) also undergo substantial degeneration in diabetic
neuropathy, the effect of hyperglycemia on SC mitochondrial proteome and mitochondrial function
has not been examined. Stable isotope labeling with amino acids in cell culture (SILAC) was used
to quantify the temporal effect of hyperglycemia on the mitochondrial proteome of primary SCs
isolated from neonatal rats. Of 317 mitochondrial proteins identified, about 78% were quantified and
detected at multiple time points. Pathway analysis indicated that proteins associated with
mitochondrial dysfunction, oxidative phosphorylation, the TCA cycle and detoxification were
significantly increased in expression and over-represented. Assessing mitochondrial respiration in
intact SCs indicated that hyperglycemia increased the overall rate of oxygen consumption but
decreased the efficiency of coupled respiration. Although a glucose-dependent increase in superoxide
production occurs in embryonic sensory neurons, hyperglycemia did not induce a substantial change
in superoxide levels in SCs. This correlated with a 1.9 fold increase in Mn superoxide dismutase
expression which was confirmed by immunoblot and enzymatic activity assays. These data support
that hyperglycemia alters mitochondrial respiration and can cause remodeling of the SC
mitochondrial proteome independent of significant contributions from glucose-induced superoxide
production.
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A severe and prevalent complication of diabetes is the development of diabetic peripheral
neuropathy (DPN) 1. Hyperglycemia and poor control of blood glucose are precipitating events
that initiate a series of complex and inter-related metabolic and vascular insults that underlie
the etiology of diabetic neuropathy. Two pathogenetic components that contribute to DPN are
enhanced oxidative stress and mitochondrial dysfunction in both sensory neurons and Schwann
cells (SCs) 2, 3. Using cultured endothelial cells, Brownlee and colleagues were the first to
suggest that increased mitochondrial superoxide production may be a unifying biochemical
lesion which promotes hyperglycemia-induced increases in polyol synthesis, protein kinase C
activity, protein modification by N-acetyl glucosamine and formation of advanced glycation
end products in endothelial cells 4, 5. Consistent with this hypothesis, pharmacological
interventions that decrease superoxide production and protein nitration in peripheral nerve
improve morphological and physiological indices of nerve damage that contribute to diabetic
neuropathy 6–9.
Although hyperglycemia can increase oxidative stress in mitochondria10, it is unclear whether
glucose-induced superoxide production may contribute to changes in mitochondrial protein
expression and function. SCs undergo substantial degeneration in DPN but the broad effect of
hyperglycemia on the SC mitochondrial proteome has not been examined. To this end, we used
stable isotope labeling of cells in culture (SILAC) to establish an unbiased and temporally
dynamic assessment of the effect of hyperglycemia on the SC mitochondrial proteome. SILAC
has been used extensively for quantifying changes in organellar proteomes 11 and requires at
least two distinct populations of SCs that are differentially labeled with, for example, 12C-Lys
or 13C6-Lys. After 5–6 population doublings, the SCs readily incorporate the 13C6-Lys into
their proteome such that at least 95% incorporation is obtained within 10 days 12. After the
labeling period, one population of the cells serves as a control and the other is subjected to
hyperglycemic stress for various periods of time. Cell lysates are then prepared, mixed together
in a 1:1 mass ratio and specific sub-proteomes are enriched prior to analysis 13.
In the present study, SCs subjected to hyperglycemic stress for 2, 6 or 16 days exhibited an
overall increase in the expression of numerous mitochondrial proteins associated with a broad
range of biochemical functions. Although hyperglycemia increased the expression of protein
components of the respiratory chain, this correlated with a decreased mitochondrial efficiency
toward ATP generation. Concurrent measures of the rate of extracellular acidification indicated
a shift toward glycolysis. Unexpectedly, we found that hyperglycemia did not significantly
increase superoxide production either acutely (< 6 hrs) or under conditions of more prolonged
hyperglycemia (6 days) using two fluorimetric dyes. The lack of glucose-induced superoxide
generation may arise in part from an increase in mitochondrial Mn-SOD. These data suggest
that neonatal rat SCs are rather insensitive to glucose-induced superoxide generation in the
mitochondria and that hyperglycemia affects the mitochondrial proteome independent of this
marker of oxidative stress.
Experimental Section
Schwann Cell Isolation and Metabolic Labeling
Schwann cells (SCs) were isolated as described and were cultured in low glucose (5.5 mM)
DMEM that was custom prepared conformed to Gibco DMEM (#12320), with the exception
that L-arginine and L-lysine were omitted12. Complete medium contained the specified
isotopic forms of Lys or Arg, 100 U/ml penicillin, 100 µg/ml streptomycin, 10% dialyzed FCS
(dFCS, Atlas Biologicals, Fort Collins, CO) and 2 µM forskolin. In experiments not requiring
stable isotopes, the medium was supplemented with 84 mg/l 12C-Arg and 125 mg/l 12C-Lys
(K0). For SILAC analysis, the cells were also incubated in medium supplemented with 12C-
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Arg and U-[13C6]-L-Lys (13C6-Lys, K6). Primary SCs were used for 5 passages and were
maintained in the labeling medium for at least 10 days prior to mass spectrometric analysis
since this is the minimal labeling period necessary to obtain about 95% isotopic enrichment of
the proteome 12. All the amino acids were prepared as 100x stock solutions in serum-free Arg/
Lys deficient DMEM, sterile filtered and added to working volumes of medium. Unlabeled
amino acids were obtained from Sigma Chemicals (St. Louis, MO) and >98% isotopically
enriched amino acids were a product of Cambridge Isotopes (Andover, MA); no correction for
isotopic purity was made in the quantitative measures.
Cell Fractionation for SILAC Analysis
For proteomic analysis, 10 ×15 cm plates of SCs were expanded in K0 or K6 complete medium
yielding about 4 × 107 cells per treatment. Since it was necessary to passage the primary SCs
twice to obtain a sufficient cell number to seed into the ten plates, they have already been
labeled to metabolic equilibrium. At this point, the Lys concentration was also decreased to
62.5 mg/l in both the K0 and K6 cultures to conserve the metabolic label and forskolin was
not added to the medium to avoid possible confounding effects due to the growth promoting
activity of the drug. After the cells became established, hyperglycemia was induced by
adjusting the glucose concentration to 30 mM in the K6 or cultures (K0 in the reverse labeling
experiment) and both sets of cells were incubated for 2, 6 or 16 days with a medium change
every third day. The cells were trypsinized, washed twice with ice-cold phosphate-buffered
saline (PBS) and resuspended in 10 ml of mitochondrial isolation buffer (MIBA) containing
10 mM Tris-HCl, pH 7.4, 1 mM EDTA, 0.2 M D-mannitol, 0.05 M sucrose, 0.5 mM sodium
orthovanadate, 1 mM sodium fluoride and 1× Complete® Protease Inhibitors (Roche
Diagnostics) 14. The cells were homogenized with the aid of a Teflon pestle and lysis was
confirmed microscopically. The protein concentration of each lysate was measured in
quadruplicate using the Bradford assay and bovine serum albumin as the standard. The
coefficient of variation was determined for each set of quadruplicate measures and if the
variability exceeded 5%, the protein assay was repeated for that set of samples. The samples
were then mixed together in a 1:1 mass ratio yielding 24–30 mg of protein.
Nuclei were isolated from the pooled lysates by centrifugation at 500 × g at 4°C for 5 min. The
crude nuclei were washed with PBS and further purified as described below. The remaining
S1 supernatant was centrifuged at 8,000 × g for 10 min at 4°C, yielding the S2 supernatant and
the heavy mitochondrial (HM) fraction. The HM fraction was washed twice with MIBA and
resuspended in 3 ml of 25% Nycodenz prepared in 10 mM Tris-HCl, pH 7.4,1 mM EDTA,
0.25M sucrose. Mitochondria were purified by centrifugation at 50,000×g for 90 min at 4°C
in a SW41 rotor over a discontinuous gradient of 40%, 34%, 30%, 25% (HM), 23% and 20%
Nycodenz as described 14. The mitochondria that sedimented at the 25%–30% interface were
recovered, the fraction was diluted with MIBA and the mitochondria pelleted by centrifugation
at 10,000 × g for 10 min at 4°C. The final mitochondrial pellet was resuspended in 0.1–0.15
ml MIBA.
A cytosolic fraction was obtained from the S2 supernatant by centrifugation at 100,000 × g for
60 min at 4°C. The resulting cytosol was concentrated at 4°C to less than 0.5 ml using an
Amicon Ultra filter device with a 10,000 nominal molecular weight limit. Nuclei were purified
following the procedure of Hwang et al. 15. Briefly, the crude nuclei were resuspended in 20
mM HEPES-KOH, pH 7.5, 10 mM KCl, 1 mM EDTA, 1 mM DTT, 0.25 M sucrose and mixed
with an equal volume of 20 mM HEPES-KOH, pH 7.5, 10 mM KCl, 1 mM EDTA, 1 mM
DTT, 2.3 M sucrose (both buffers contained the Complete protease inhibitor cocktail). The
nuclei sample was then layered directly over the 2.3 M sucrose buffer and centrifuged at 60,000
× g for 90 min at 4°C in a SW41 rotor. The nuclear pellet was washed with MIBA and
resuspended in 0.1–0.15 ml of this buffer.
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To assess organelle enrichment, 3 µg of protein was fractionated by SDS-PAGE. After transfer
to nitrocellulose, immunoblot analysis was performed using the following antibodies against
marker proteins for mitochondria, MnSOD (Upstate Biotechnology, Lake Placid, NY) and
prohibitin-1 (Neomarkers, Freemeont, CA); nuclei, p62 nucleoporin (BD Transduction Labs,
Lexington, KY); endoplasmic reticulum, GRP 78 (Santa Cruz Biotechnology, Santa Cruz, CA);
and cytosol, lactate dehydrogenase (Sigma-Aldrich, St. Louis, MO).
Mass Spectrometry and Protein Identification
Proteins were identified following one-dimensional SDS-PAGE coupled to RP-HPLC linear
quadrupole ion trap Fourier transform ion cyclotron resonance tandem mass spectrometry
(GeLC-LTQ-FT MS/MS) 16. About 75–100 µg of protein was fractionated by SDS-PAGE, the
proteins were visualized by staining the gel and the lane was cut into 12–15 sections for in-gel
tryptic digestion.
The gel pieces were placed in silanized microfuge tubes and destained with 100mM ammonium
bicarbonate in 50% acetonitrile 17. Following reduction (10mM dithiothreitol at 55°C for 1 hr)
and alkylation (55mM iodoacetamide for 30 min in the dark at room temperature), the gel
pieces were washed with 100mM ammonium bicarbonate in 50% acetonitrile, dehydrated with
100% acetonitrile and dried. The gel pieces were rehydrated on ice in a minimal volume of 25
mM ammonium bicarbonate, pH 7.5 containing 12.5 ng/µl Trypsin Gold (Promega Corp.,
Madison, WI), covered with a sufficient volume of 25 mM ammonium bicarbonate, pH 7.5
and the proteins were digested overnight at 37°C. The peptides were extracted from the gel
particles with 5% formic acid in 100 mM ammonium bicarbonate and 5% formate in 100%
acetonitrile. The combined supernatants were concentrated to ~25 µl in a Speed-Vac prior to
analysis.
Peptides were separated on a micro-capillary reverse-phase column (either 0.30 × 150 mm,
Pepmap C18, or 0.32 × 50 mm, MicroTech Scientific) at a flow rate of 5 –10 µl/min with a
linear gradient from 5 to 65% acetonitrile in 0.06% aqueous formic acid (v/v) over 55 min and
the eluate was introduced into the LTQ-FT tandem mass spectrometer (ThermoFinnigan,
Waltham, MA). All experiments were performed in data-dependent mode using dynamic
exclusion with survey MS spectra (m/z 300–2000) acquired in the FT-ICR cell with resolution
R = 25,000 at m/z 400 and accumulation to a target value of 5×105 charges or a maximum ion
accumulation time of 2000 ms. The three most intense ions were isolated and fragmented with
a target value of 2 ×103 accumulated ions and an ion selection threshold of 3000 counts.
Dynamic exclusion duration was typically 200 sec with early expiration if ion intensity fell
below a S/N threshold of 2. The ESI source was operated with a spray voltage of 2.8 kV, a
tube lens offset of 170 V and a capillary temperature of 200 °C. All other source parameters
were optimized for maximum sensitivity of a synthetic YGGFL peptide ion at m/z 556.27.
The MS/MS peak list was generated from the Xcalibur raw files using DTA Supercharge (v
1.17) (http://msquant.sourceforge.net). The individual text files were linked to their
corresponding LTQ-FT raw file and concatenated with the aid of an in-house modified Perl
script (MultRawPrepare) originally obtained from the MSQUANT web address. The
concatenated file was submitted to Mascot (v. 2.1, Matrix Science, London, United Kingdom)
and proteins were identified by searching a combined IPI mouse/rat (v3.26) database
concatenated with their reverse sequences (188,450 total sequences). Search parameters
specified a maximum mass deviation of 10 ppm, a fragment tolerance of 0.5 Da, up to1 missed
cleavage and carboxyamidomethylated cysteine as a fixed modification. Variable
modifications were set to consider protein N-terminal acetylation, N-terminal pyro-glutamine,
methionine oxidation and the presence of 13C6-Lys. The Mascot search results were imported
into Scaffold Protein Identification software (v 2.0, Proteome Software, Portland, OR) and
reanalyzed using the X! Tandem search algorithm to enhance and further validate peptide and
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protein identification. The peptide filter was set to a 95% confidence level and proteins
validated by Scaffold at this confidence level or greater were considered identified without
further verification. Manual verification of other proteins, especially those identified by a single
peptide, followed an acceptance criteria which required a fully tryptic peptide that was at least
7 amino acids in length, had a detected series of at least 4 consecutive y-ions or b-ions and a
Mascot ion score of 25 or greater at a mass deviation of ≤ 6 ppm (3 times the dispersion of the
mass deviations). Using these criteria for peptide identification, the overall false positive rate
was estimated18 as <0.5% between the various time points used in the proteomic analyses.
To asses the statistical mass accuracy between the experiments, the distribution of calibrated
mass errors for all peptides initially identified in the search was obtained from MSQUANT
and the errors were binned by 2 ppm intervals 19. The errors between the mitochondrial analyses
followed a normal distribution and the average calibrated absolute mass deviation was 2.63 ±
0.21 ppm and the average dispersion was 1.97 ± 0.19 ppm. (Supplemental Fig. 1).
Protein Quantification, Statistical and Bioinformatic Analyses
The expression ratio of individual peptide pairs was obtained using MSQUANT 20. However,
it was also necessary to manually quantify peptide pairs and verify a subset of the MSQUANT
results using peak intensities from Xcalibur software (v2.0 SR1). If similar peptides of different
charge states were detected, only the peptide with the highest ion score was counted toward
identification and quantified. Similarly, redundant peptides containing a modification were
only counted toward identification and quantified if an un-modified peptide was not detected.
If multiple peptide pairs were quantified for the same protein, an overall protein expression
ratio was taken as the average of these measures and the standard deviation was determined.
The protein lists from MSQUANT were imported into Protein Center (Proxeon Bioinformatics,
Odense, Denmark) and redundant mouse-rat orthologs and database entries were removed after
clustering at 60% homology. The anchor protein used for clustering a given group of proteins
is indicated in Supplementary Tables 1–3.
As previously reported, 3 times the average standard deviation of all the expression ratios at a
given time point was assigned as the threshold for indicating a significant change 21. For
example, of 1,251 proteins identified at all times points in the mitochondrial fractions, 991
(79%) were quantified and 556 were quantified by ≥2 unique peptides. The average standard
deviation obtained in these three separate experiments was 0.111 ± 0. 02, indicating that the
analytic variability was tightly clustered at about 11%. Using the above criterion, proteins
whose expression ratios were < 0.67 or > 1.33 were defined as showing a significant change.
Proteins were automatically annotated with respect to cell localization using Protein Center
and via manual annotation from the SwissProt database. Bioinformatic analyses were
performed using Ingenuity Pathway Analysis (v 7.0, Ingenuity Systems, Redwood CA) and
BinGO 22. After setting a bidirectional 1.3 fold change as the threshold, the program identified
statistically over or under represented molecular networks. Pathways with p <0.001 using the
HyperGeometric test after correcting for multiple term testing by the Benjamini & Hochberg
False Discovery Rate (B-H FDR) were deemed enriched.
Mitochondrial Respiration and Extracellular Acidification Measures
The rates of O2 consumption (OCR) and extracellular acidification (ECAR) were assessed on
intact SCs using an Extracellular Flux Analyzer (Seahorse Biosciences, North Billerica, MA).
Extracellular flux analysis is a non-invasive assay which uses two calibrated optical sensors
which directly measure OCR and ECAR in cells that remain attached to the culture plate. This
technique avoids variability associated with trypsinization and mechanical stirring of the cells
to determine OCR. Primary SCs were treated with 5.5 mM or 30 mM glucose for 3 days and
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baseline respiration was determined. Respiratory chain inhibitors were sequentially injected
into the wells and ATP-coupled oxygen consumption was calculated as the oxygen
consumption rate sensitive to 1 µM oligomycin, an ATP synthase inhibitor, after correcting
for nonmitochondrial respiration. Proton leak was calculated as the mitochondrial rate
insensitive to oligomycin, after correcting for non-mitochondrial respiration. The maximal
uncoupled respiration rate was determined by depolarizing the mitochondrial membrane
potential with 1 µM FCCP (carbonylcyanide-4-(trifluoromethoxy)-phenylhydrazone) and non-
mitochondrial respiration was determined as the activity remaining after inhibition of
complexes 1 and 3 with 1 µM rotenone and 1 µM myxothiazol, respectively. Changes in ECAR
are an indirect assessment of glycolytic activity due to lactic acid production and proton
extrusion and were measured concurrent with oxygen consumption 23. After the measures, the
cells were harvested, protein concentration of each well was determined and experimental rate
values were normalized to protein content.
Superoxide Assessment and Mn-SOD Activity assay
Superoxide levels were measured by following the oxidation of dihydroethidine (Invitrogen-
Molecular Probes, Carlsbad, CA) to ethidium 24. SCs were seeded at 1 × 104 cells per well in
96 well plates and were treated with 5.5 mM or 30 mM glucose for the indicated times once
reaching about 90% confluency. At the end of the incubation, the cells were incubated with 15
µM dihydroethidine for 15 mins at 37°C. The cells were washed with PBS and the ratio of
ethidium (excitation 530 nm, emission 590 nm) to dihydroethidine (excitation 485 nm,
emission 530 nm) was determined with the cells attached to the plate using a fluorescence
spectrometer.
For assessing superoxide production using MitoSOX Red25, SCs were grown in low glucose
DMEM in six well plates until confluent. Cells were incubated in medium containing 5.5 mM
or 30 mM glucose for 6 days and the cells were washed once with OPTI-MEM medium.
MitoTracker Green (80 nM) was added to each well and after 10 min, 2.25 µM MitoSOX Red
was added into the wells and the cells incubated for an additional 10 mins. The cells were
washed twice with fresh OPTI-MEM medium prior to imaging on an Olympus 3I Spinning
Disk confocal microscope using excitation/ emission wavelengths of 575/624 nm (MitoSox
Red) and 494/531 nm (MitoTracker Green). As a positive control, some cells were treated with
1.8ug/ml Antimycin A in OPTI-MEM medium with 1% BSA for 25 mins. Fluorescence
intensity of the red and green signals of at least 200 cells per treatment was obtained using
CellProfiler and CellProfiler Analyst image analysis software.
To assess manganese superoxide dismutase (Mn-SOD) activity, SCs were seeded into 10 cm
plates and treated with 5.5 mM or 30 mM glucose for the indicated times after reaching about
90% confluency. The cells were trypsinized and three plates per treatment were combined to
isolate a heavy mitochondrial fraction as described above. Mn-SOD activity was determined
as described by the manufacturer (Dojindo Molecular Technologies, Gaithersburg, MD) using
0.5 – 3 µg of the heavy mitochondrial fraction. To inhibit Cu/Zn SOD, the protein was
preincubated with 2 mM KCN for 30 mins at 4°C prior to assaying for MnSOD activity 14.
Results
Analysis of the SC Organellar Fractions
Although the primary focus of the study was on assessing the effect of hyperglycemia on
altering the mitochondrial proteome, nuclei and cytosolic fractions were also isolated as
described in the Experimental Methods (Fig. 1A). Organelle purity was assessed following
SDS-PAGE of and immunoblot analysis for the presence of established protein markers of
nuclei, mitochondria, endoplasmic reticulum and cytosol (Fig. 1B). As expected, the
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mitochondrial fraction was enriched in the inner mitochondrial membrane and matrix proteins,
prohibitin 1 and MnSOD. Neither marker protein for cytosol (lactate dehydrogenase) or nuclei
(p62 nucleoporin) was detected in the purified mitochondrial fraction but it did remain
contaminated with endoplasmic reticulum. Indeed, we repeatedly found GRP78 in most
fractions and it proved difficult to remove from the mitochondrial fraction by using either
Nycodenz or Percoll discontinuous gradients (). Although GRP78 is a resident protein of the
endoplasmic reticulum, it is also secreted from the organelle which may contribute to its
cytosolic localization.
Hyperglycemia has temporally distinct effects on nuclear and mitochondrial protein
expression
To perform a temporal analysis of the effect of hyperglycemia on the SC proteome,
metabolically labeled cells (K6) were treated with 30 mM glucose for 2, 6 or 16 days while
unlabeled control cells (K0) were maintained in 5.5 mM glucose at each time point. This time
course was chosen to model the effect of acute and more chronic hyperglycemia on the primary
SCs. Although triple labeling can be performed for temporal analyses by SILAC 26, we only
used 13C6-Lys as a single metabolic label and performed three separate experiments to cover
the time course. Mitochondrial, nuclear and cytosolic proteins were separated by SDS-PAGE,
in-gel digested with trypsin and the peptides were analyzed by GeLC-LTQ-FT MS/MS. The
acquired mass spectra were searched against a combined mouse-rat IPI database and we
identified 1,673 proteins from the various cell fractions at all time points and 1,198 (71.6%)
of these proteins were unique.
Analysis of the nuclear fraction identified 332 total proteins, of which, 64% were detected at
2 or more time points (Fig 2A). Among the total proteins identified in this fraction, resident
nuclear proteins were identified by their gene ontology (GO) annotation and 213 nuclear
proteins were quantified using 1,145 peptides (Supplementary Table 1). In order to broadly
compare the temporal effect of hyperglycemia on the nuclear proteome, the quantified proteins
were ranked by their expression ratio and plotted versus protein number (Fig. 2B) or the
expression ratios were binned and the percent of proteins per bin was determined (Fig. 2C).
Increases in nuclear protein expression were rather similar between 2 and 16 days of
hyperglycemia with 40% and 51% of the quantified proteins showing a statistically relevant
increase, respectively. In contrast, 6 days of hyperglycemia led to 35% of the nuclear proteins
showing a decreased expression. On the other hand, hyperglycemia had little effect on proteins
identified in the cytoplasmic fraction (Supplementary Table 2). Although the majority of
cytoplasmic proteins showed no significant change after 2 (91.7%) or 6 (84.0%) days of
hyperglycemia, about 34% of the quantified proteins showed an increased expression after 16
days (Figs. 2D and E).
BinGO was used to determine if any biological processes were over-represented among the
nuclear proteins that showed a significant change in their expression ratio after hyperglycemic
stress 22. Proteins affecting chromatin regulation, DNA remodeling and transcription were
over-represented after 2 days of hyperglycemia (Fig. 3A). This result was consistent with the
pathway analysis which found that the top two molecular networks affected by hyperglycemia
were associated with increases in mRNA processing, splicing and modification and DNA repair
(Fig. 3B). Conversely, proteins associated with protein transport, biosynthesis and metabolism
were either marginally decreased or unchanged, especially since the majority of these proteins
are cytoplasmic.
Mitochondrial proteins were identified by their GO annotation in Protein Center and by filtering
against a reference set of 1,022 mouse mitochondrial proteins downloaded from the MitoP2
project (http://141.39.186.157:8080/mitop2/, last updated Nov. 2008). Using this approach,
we identified 317 unique proteins that either reside or are associated with mitochondria and
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detected 242 proteins (76.3%) at two or more time points (Fig. 4A). Using 1,599 peptides, 248
proteins were quantified but the detection of only Arg-containing tryptic peptides negated
quantification of the remaining 69 proteins. Only 16 (5.0%) non-quantifiable mitochondrial
proteins were identified by a single peptide at a single time point and the ion scores and MS2
spectra for these peptides are shown in Supplementary Table 3.
After 2 or 6 days of hyperglycemia, approximately 90% of all mitochondrial proteins showed
a statistically relevant increase (Fig. 4B). However, about 21% of the proteins increased
expression ≥1.9-fold after 6 days of hyperglycemia compared to only 7.0% and 1.1% after 2
or 16 days of glycemic stress (Fig. 4C). Indeed, after 16 days of hyperglycemia, only 56% of
the mitochondrial proteins increased above 1.3 fold.
The analytic and biologic confidence of these changes is strengthened by the observation that
when the SILAC experiment was reversed (K6 cells as control and K0 subjected to 6 days of
hyperglycemia), the overall effect on the mitochondrial proteome was similar (Fig. 4B).
Secondly, immunoblot analysis for prohibitin 1 showed a similar increase in expression after
6 days of hyperglycemia as was determined by the SILAC analysis (Supplementary Fig. 2).
Additionally, proteins known to exist in a 1:1 subunit stoichiometry showed similar changes
at each time point 27. For example, after 2 days of hyperglycemia, quantitation of 6 –10 peptides
identifying the α and β subunits of ATP synthase indicated an increase of 1.66±0.11 and 1.49
±0.11, respectively. Agreement between changes in ATP synthase subunit levels was also
preserved after 6 (1.50±0.09 and 1.59±0.11) or 16 days (1.30±0.12 and 1.369±0.11) of
hyperglycemia. Similarly, the relative change in the α and β subunits of the E1 component of
the pyruvate dehydrogenase were tightly correlated (Supplementary Table 3). Lastly, the
average expression ratio of all contaminating non-mitochondrial proteins did not show a
statistically relevant change after 6 (176 proteins) or 16 (228 proteins) days of hyperglycemia
although a 1.42 fold increase was noted after 2 days of hyperglycemia (145 proteins).
Hyperglycemia increases the expression of proteins contributing to mitochondrial
dysfunction and decreases the efficiency of oxidative phosphorylation
The above analysis strongly suggests that the mitochondrial proteome undergoes a marked
increase in protein expression during hyperglycemia stress. This response would suggest that
proteins involved in coordinated metabolic functions such as glucose metabolism, oxidative
phosphorylation, lipid metabolism, stress response mediators and gene expression may respond
in a concerted manner. Clustering the mitochondrial proteins by functional class showed that
the quantified components of the mitochondrial respiratory chain exhibited a significant
increase in expression after 2 and 6 days of hyperglycemia (Fig. 5A). This corresponded with
a 1.6 to 1.8-fold increase in components of the TCA cycle which provides the reducing
equivalents utilized by the respiratory chain. However, after 16 days, there was a significant
decline in expression of proteins associated with the TCA cycle as well as with complexes I
and V.
To identify the top metabolic processes affected by hyperglycemia over time, the data sets were
subjected to pathway analysis. Mitochondrial dysfunction, oxidative phosphorylation and the
TCA cycle were among the top over-represented canonical pathways after 2 or 6 days of
hyperglycemia (Fig. 5B). These data are consistent with previous work which demonstrated
that hyperglycemia increased the transcript levels for components of oxidative phosphorylation
in diabetic sensory ganglia 28. Proteins annotated to mitochondrial dysfunction were linked
primarily to the regulation of respiration and detoxification of reactive oxygen species.
Since proteins associated with the TCA cycle and oxidative phosphorylation were increased,
this suggested that hyperglycemia was affecting mitochondrial activity. SCs were subjected to
hyperglycemic stress for three days and the rate of oxygen consumption was measured over 2
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hrs using intact SCs. Since the oxygen consumption rates (OCR) and extracellular acidification
rates (ECAR) are affected by metabolic activity and the number of cells 23, both indices were
normalized to total protein. Hyperglycemia increased the overall rate of oxygen consumption
and part of this effect was related to a 1.5 fold increase in non-mitochondrial oxygen
consumption by hyperglycemia: basal OCR minus rotenone + myxothiazol insensitive OCR
(Fig. 6A). Coupled respiration and proton leak were determined using the ATP synthase
inhibitor, oligomycin. In the presence of 5.5 mM glucose, SCs devoted 88.2 ± 16.6% of their
mitochondrial respiration for ATP production and 11.8 % to proton leak. Under hyperglycemic
conditions, ATP coupled respiration decreased to 64.5 ± 12.2% and proton leak increased to
35.4%. Thus, hyperglycemia decreased mitochondrial efficiency by uncoupling oxygen
consumption from ATP production. Consistent with a decrease in the efficiency of oxidative
phosphorylation, hyperglycemia increased extracellular acidification by 2.1 ± 0.4 fold,
suggesting an increase in the rate of glycolysis (Fig. 6B) 29.
Hyperglycemia increased the expression of MnSOD but not the production of superoxide
anion
Proteins annotated to mediating mitochondrial detoxification responses showed the largest
increase as a class after 6 days of hyperglycemia. Among this group, SILAC analysis indicated
that MnSOD (Fig. 7A) expression increased about 2.0 fold after 6 days of hyperglycemia. The
increase in Mn-SOD was specific since a similar change was not observed in the cytosolic Cu/
Zn SOD (Fig. 7B). These differences were confirmed in separate experiments by immunoblot
analysis as well. SCs were treated with 5.5 mM or 30 mM glucose for 2–6 days and heavy
mitochondrial and cytosolic fractions were obtained. Curiously, the magnitude of the increase
in MnSOD in the heavy mitochondrial fraction seemed slightly greater by immunoblot analysis
but was nonetheless consistent with that observed in the purified mitochondria (Figs. 7C &
7E). Confirming the mass spectrometric analysis, hyperglycemia did not increase cytosolic
levels of CuZn SOD (Fig. 7D). Consistent with our proteomic data, MnSOD activity also
increased by 2–2.5 fold after 4–6 days of hyperglycemia (Fig. 8A). Lastly, to rule out that the
observed changes were the result of osmotic stress, SCs were incubated with 30 mM L-glucose
or mannitol for 6 days and a heavy mitochondrial fraction was isolated. No change was
observed in the expression of Mn-SOD and prohibitin 1 (data not shown). Since L-glucose is
not metabolized, these data suggest that osmotic stress was not sufficient to alter mitochondrial
protein expression.
Glucose-induced production of superoxide within mitochondria has been suggested to be a key
biochemical feature of glucotoxicity 9, 30. Surprisingly, no significant change in total cellular
superoxide levels was observed in the SCs even after prolonged hyperglycemia (Fig. 8B). On
the other hand, previous studies in embryonic sensory neurons cultured for several days in vitro
have suggested that glucose-induced superoxide generation may occur shortly after exposure
to high glucose 24. However, even after 4 – 6 hrs of hyperglycemia, we observed no significant
increase in superoxide generation (data not shown). Since the above study monitored the
cellular conversion of hyroethidine to ethidium, we next used the mitochondrially targeted
derivative of hydroethidine, MitoSox Red along with co-staining for mitochondria using
MitoTracker Green to more directly visualize if hyperglycemia increased superoxide in the
mitochondria. Similar to the above results, six days of hyperglycemia did not significantly
enhance mitochondrial superoxide production (Figs. 8C and 8D). However, the mitochondria
were actively capable of producing this molecule since a brief incubation with antimycin A
clearly increased mitochondrial superoxide generation as shown by the increase intensity of
the yellow fluorescence.
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To date, few studies have used SILAC as an approach to examine the effect of hyperglycemic
stress on primary cells that regulate glucose uptake or contribute to diabetic complications.
However, the utility of SILAC in identifying novel proteins that may contribute to diabetes is
highlighted by a recent report showing that cultured myotubes from extremely obese women
secreted almost 3 times more myostatin than myotubes obtained from lean or moderately obese
patients 31. Additionally, SILAC has been used to characterize the phosphoproteome of the
insulin signaling pathway 21, 32, 33. In the present study, we provide the first quantitative
characterization of the temporal effect of hyperglycemia on the proteome of cultured primary
SCs using SILAC.
One benefit of the SILAC approach is that the isotopically-enriched amino acid is not
preferentially incorporated into a given subproteome if a sufficient labeling period is
performed. Therefore, we characterized the broad effect of hyperglycemia on the SC proteome
by isolating cytoplasmic, nuclear and mitochondrial subcellular fractions. After 2 days of
hyperglycemia, nuclear proteins affecting chromatin regulation, DNA remodeling and
transcription increased but the mean expression ratio was 1.03 for all the proteins identified in
nuclear fraction, suggesting a limited global effect. Similarly, hyperglycemia had little effect
on altering cytoplasmic proteins at all time points but one cytoplasmic enzyme worth noting
is aldose reductase. It is well recognized that an increase in aldose reductase activity contributes
to the pathophysiology of diabetic neuropathy34, 35. Although we did not assess aldose
reductase activity in the present study, the unbiased identification of aldose reductase indicated
that its expression was unaffected by hyperglycemic stress in the cultured SCs. This lack of
change in aldose reductase expression is consistent with previous reports that its mRNA level
is not induced in hyperglycemic rat SCs 36 and that aldose reductase immunoreactivity does
not increase in SCs of diabetic rat sciatic nerve37.
In large part, hyperglycemia had the greatest effect on the SC mitochondrial proteome since
the average expression ratio was 1.51 for all proteins identified in the mitochondrial fraction.
This result is consistent with previous reports that numerous mitochondrial proteins were
increased in hearts obtained from OVE26 mice that were diabetic for 18 weeks38 and in
cardiomyocytes from acutely hyperglycemic rats 39. For example, aconitase, ATP synthase
α, prohibitin, ATP synthase D chain and GTP specific succinyl CoA synthetase increased to a
similar level in both the hyperglycemically stressed SCs and in diabetic rat heart mitochondria
38. Interestingly, we also observed an increase in up-regulated during skeletal muscle growth
protein 5, a poorly characterized mitochondrial protein which associates with ATP
synthase40. This protein is also known as diabetes-associated protein in insulin sensitive tissues
(DAPIT) since its mRNA decreased in muscle but not brain of diabetic rats 41. Thus, DAPIT
may be a novel glucose-responsive protein that affects mitochondrial function in diabetic
tissues. Although we did not explore the mechanism by which high glucose caused such a
broad increase in mitochondrial proteins, evidence exists for an increase in mitochondrial
biogenesis in diabetic heart38. Consistent with the possibility of an acute increase in
mitochondrial biogenesis, mitochondrial transcription factor A is critical for the replication of
mitochondrial DNA42, and it was increased approximately 1.7 fold after 2 or 6 days of
hyperglycemia.
A recent report has demonstrated that diabetes induced a tissue-specific remodeling of the
mitochondrial proteome in organs derived from 6 week diabetic Akita mice that did not
necessarily correlate with changes in mitochondrial function43. For example, despite a
diabetes-induced increase in proteins involved in oxidative phosphorylation and the TCA
cycle, no changes were observed in mitochondrial respiration in organelles obtained from liver,
brain or kidney43. However, in heart mitochondria, diabetes decreased the expression of
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proteins involved in oxidative phosphorylation and the TCA cycle and this correlated with a
decrease in mitochondrial respiration. These data highlight the issue that hyperglycemic stress
can differentially affect the mitochondrial proteome and respiratory activity. Since it is difficult
to model chronic diabetes in a cell culture model, the overall increase in the SC mitochondrial
proteome in our acute cell culture model may more reflect early protective responses to
hyperglycemic rather than chronic damage. Proteomic analysis of mitochondria isolated from
dorsal root ganglia and sciatic nerve of animals rendered diabetic for various durations will
provide further insight into the utility of the primary cell models to address more mechanistic
issues contributing to changes in the proteome associated with protective versus degenerative
responses.
Despite the increase in mitochondrial respiratory proteins in heart mitochondria from diabetic
mice, the respiratory control ratio was actually lower but the coupling of ATP production and
oxygen consumption (P/O ratio) was not affected 38. Although mitochondrial respiration is
often measured using purified mitochondria, the use of the XF24 Extracellular Flux Analyzer
allowed us to use intact SCs to assess both mitochondrial and non-mitochondrial effects of
glucose on oxygen consumption and medium acidification. In 5.5 mM glucose, ~88% of the
mitochondrial oxygen consumption was coupled to ATP production in intact SCs. In contrast,
hyperglycemia decreased the amount of ATP-coupled oxygen consumption by 27% and
increased the extent of proton leak 3-fold. The decreased efficiency and increased proton leak
suggests that hyperglycemia is lowering the P/O ratio, but we did not directly assess this
parameter. Although our data does reflect the physiological response of the intact SCs to high
glucose, it is difficult to directly compare these data with the lack of a change in the P/O ratio
observed in mitochondria from diabetic heart 38 due to the different experimental conditions.
Lastly, although glycolytic proteins did not increase in expression after 2 to 6 days of
hyperglycemia, 3 days of hyperglycemia increased ECAR, which is an indirect measure of
glycolytic activity (lactic acid production) and non-glycolytic acidification from CO2
production 23. These data suggest that the cultured SCs are highly glycolytic even in the absence
of protein upregulation.
The putative physiological role of proton leak is to contribute to the uncoupling of electron
transport from ATP synthesis (heat generation) and decrease oxidative stress by reactive
oxygen species 44. Although increases in the mitochondrial membrane surface area and
phospholipid composition can affect the basal leak rate, changes in the expression of the
adenine nucleotide transporter 1 protein (ANT1) can also contribute to mild uncoupling 44.
Previous data has shown that a 1.7 fold increase in ANT1 can increase proton leak by about
1.5 fold in isolated mitochondria 45. We found that hyperglycemia induced a 1.5 fold increase
in ANT1 expression after 2–6 days (Supplementary Table 3) and this correlated with an
increased proton leak from a basal level of 12% in 5.5 mM glucose to about 35%. Although
uncoupling proteins may also contribute to enhanced proton leak, a genomic study of mouse
peripheral nerve from embryonic day 17 through adulthood found that transcripts for the
uncoupling proteins (UCP1 – 3) were not expressed 46. Thus, it is unlikely that hyperglycemia
also increases UCPs but additional studies are needed to determine if ANT1 directly contributes
to the increased proton leak.
Previous reports have proposed that mitochondrial superoxide production may be a unifying
biochemical lesion that contributes to increases in polyol synthesis and other molecular
pathologies of hyperglycemia 4, 5. However, we were not able to detect a significant increase
in superoxide production in SC following after up to 6 days of hyperglycemia and this
correlated with an increase in mitochondrial Mn-SOD expression and activity. Vincent and
colleagues recently reported a similar resistance of SCs to glucose-dependent oxidative stress
that correlated with a rapid increase in nuclear levels of Nrf2, a critical transcription factor
which regulates the expression of antioxidant genes such as superoxide dismutase, catalase,
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and heme oxygenase 1 47. Indeed, the basal activity of catalase in SCs was about 4-fold greater
than the corresponding activity in sensory neurons 47. It is also interesting to note that increased
proton leak can also protect against mitochondrial damage induced by reactive oxygen species,
such as superoxide 48, 49. Together, these results suggest that in neonatal SCs, mitochondria
may possess multiple pathways to help minimize short-term glucose-induced oxidative stress
and that hyperglycemia can alter the SC mitochondrial proteome independent of superoxide
generation. On the other hand, 24 hr of hyperglycemic stress increased superoxide levels and
overall protein nitration in commercially supplied, cultured adult human SCs 6, 50.
Unfortunately, the reason for the discrepant results between primary neonatal rat and the adult
human SCs is unclear. One possibility may reside in the maturity or natural history of the adult
human SCs. Precedence exists that developmental maturity can affect the response of cells to
hyperglycemia since 24 hr of hyperglycemia induces death of rat embryonic sensory neurons
after 3 days in culture24, 51. However, adult rat sensory neurons and embryonic sensory neurons
that have been permitted to mature and differentiate in culture for 3 weeks are both resistant
to glucose-induced apoptosis52, 53. Importantly, it is unlikely that the neonatal cells have lost
the SC phenotype and/or the ability to respond to hyperglycemic stress since they are competent
to myelinate53, a hallmark of SC function. Whether the adult human SCs are myelination
competent is unclear. Additionally, the myelinated neonatal SCs can respond to hyperglycemic
stress since the extent of neuregulin-induced demyelination was increased by high glucose
concentrations 53. Thus, primary neonatal and adult SCs may serve as complementary models
to examine the effect of glucose on the mitochondrial proteome and function in the absence of
presence of substantial superoxide production, respectively.
It is important to note that SCs undergo degeneration in diabetic neuropathy 54 and that
increased superoxide production, protein nitration and mitochondrial dysfunction contributes
to DPN 55. At first blush, these results would appear contradictory with our findings. However,
it is not surprising that the in vivo increase in superoxide and nitrotyrosine levels in SCs after
4 or more weeks of diabetes does not mimic what we observed in the primary SC cultures.
Although there are numerous possibilities for this difference, one explanation consistent with
a recent report is that protective anti-oxidant responses may be overwhelmed with increasing
duration of diabetes. For example, diabetic adult sensory neurons mount a transient anti-oxidant
response in response to ex vivo hyperglycemia that is characterized by a brief upregulation of
Mn-SOD after one day of hyperglycemia followed by a subsequent decline 52. Additional
studies are needed to determine if adult SCs mount a transient anti-oxidant response during the
early onset of diabetes that may be eventually overwhelmed with disease duration.
In conclusion, we have used quantitative proteomics to assess the effect of hyperglycemia on
the SC proteome. Hyperglycemia increased the expression of numerous mitochondrial proteins
but whether this effect is due to an increase in overall mitochondrial mass, as previously
reported in diabetic heart, remains to be determined. Glucose did not increase superoxide
production in SCs and this correlated with an increase in MnSOD and the extent of proton leak,
which may function in reducing oxidative stress. Consistent with a recent report 47, our data
support that primary, neonatal rat SCs are rather insensitive to glucose-induced oxidative stress
and that the mitochondrial proteome can undergo dynamic remodeling in response to
hyperglycemia.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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dFCS dialyzed fetal calf serum
DPN diabetic peripheral neuropathy
GeLC-LTQ-FT MS/
MS
gel electrophoresis and liquid chromatography linear quadrupole ion
trap Fourier transform ion cyclotron resonance tandem mass
spectrometry
GO Gene Ontology
PBS phosphate buffered saline
SILAC stable-isotope labeling with amino acids in cell culture
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Figure 1. Assessment of Organelle Purity
K0 and K6 primary SCs were cultured for 16 days in 30 mM glucose, lysates were prepared
and mixed together in a 1:1 mass ratio. Nuclear, mitochondrial and cytosolic fractions were
isolated and 75 µg of protein was separated by SDS-PAGE for proteomic analysis (A) or 3 µg
was subjected to immunoblot analysis (B) for the indicated organelle marker.
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Figure 2. Hyperglycemia has Differential Effects on the Nuclear and Cytoplasmic Proteomes
SCs were incubated in medium containing 5.5 mM (K0) or 30 mM (K6) medium for 2, 6 or
16 days and nuclear and cytoplasmic fractions were analyzed by GeLC-LTQ-FT MS/MS.
(A) Venn diagram of number and percent of annotated nuclear proteins identified at each time
point. To compare the effect of 2, 6, or 16 days hyperglycemia on the nuclear (B,C) or
cytoplasmic (D,E) proteomes, the expression ratios were plotted versus protein number
(B,D) or binned by 0.2 units and expressed as a percent of the total quantified proteins (C,E).
Line indicates three times the standard deviation of the analytic variability and proteins between
the lines did not show a significant change.
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Figure 3. Identification of Functional Classes of Nuclear Proteins Affected by Hyperglycemia
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A) Quantified proteins were grouped based upon their annotated function. The expression
ratios of all proteins associated with a function were averaged and the line indicates three times
the standard deviation of the analytic variability associated with the quantitation. Categories
above or below these limits define a significant change in expression. The number of quantified
proteins per category is indicated in the legend. Significant differences between time points
were determined using a one-way ANOVA and Tukey’s post hoc test. *, p< 0.05 compared to
2 days, ^, p < 0.05 compared to 6 days. B) The top two molecular networks affected after 2
days of hyperglycemia were identified using Ingenuity Pathway Analysis, merged and
graphically presented to highlight the increase in proteins regulating mRNA processing and
the decrease in proteins regulating protein synthesis, metabolism and transport. Gene names
are identified in Supplementary Table 4.
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Figure 4. Temporal Profile of the Effect of Hyperglycemia on the Mitochondrial Proteome
SCs were incubated in medium containing 5.5 mM (K0) or 30 mM (K6) medium for 2, 6 or
16 days and mitochondrial fractions were analyzed by GeLC-LTQ-FT MS/MS. (A)Venn
diagram of number and percent of annotated mitochondrial proteins identified at each time
point. To compare the effect of 2, 6, or 16 days hyperglycemia on the mitochondrial proteome,
the expression ratios were plotted versus protein number (B) or binned by 0.2 units and
expressed as a percent of the total quantified proteins (C). Reverse label indicates results from
an experiment where control cells were labeled in K6 medium. Line indicates three times the
standard deviation of the analytic variability and proteins between the lines did not show a
significant change.
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Figure 5. Temporal Effect of Hyperglycemia on Functional Classes of Mitochondrial Proteins
A) Quantified proteins were grouped based upon their annotated function. The expression
ratios of all proteins associated with a function were averaged and the line indicates three times
the standard deviation of the analytic variability associated with the quantitation. Categories
above or below these limits define a significant change in expression. The number of quantified
proteins per category is indicated in the legend. Significant differences between time points
were determined using a one-way ANOVA and Tukey’s post hoc test. #, p< 0.05 compared to
2 days, *, p < 0.05 compared to 2 and 6 days. FAM, fatty acid metabolism; Ox Phos, oxidative
phosphorylation. B) The top over-represented toxicologic functions were identified using
Ingenuity Pathway Analysis. Ordinate values are –log of the Benjamini-Hochberg False
Discovery Rate p-value.
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Figure 6. Hyperglycemia Increased the Oxygen Consumption Rate and Extracellular Acidification
SCs were subjected to hyperglycemic stress for 3 days and the oxygen consumption rate (OCR)
(A) and extracellular acidification rate (ECAR) (B) were measured in intact cells using an
Extracellular Flux Analyzer. Oligomycin, FCCP and rotenone/myxothiazole were added at the
indicated times to determine the rate of proton leak and O2 coupled ATP production.
Respiration experiments were repeated three times and the results presented are four replicate
measures per time point from one representative experiment.
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Figure 7. MnSOD but not Cu/Zn SOD Increased with Hyperglycemic Stress
SCs were incubated with 5.5 mM (K0) or 30 mM (K6) glucose for 6 days and mitochondrial
and cytosolic fractions were isolated. Spectra show MS1 scans indicating an increase in
intensity of a representative labeled peptide from mitochondrial MnSOD (A) but no change in
intensity of a labeled peptide for cytosolic Cu/Zn SOD (B). The expression of MnSOD (C) or
CuZn SOD (D) was determined by immunoblot analysis using a heavy mitochondrial fraction
and cytosolic fraction prepared from SCs were treated for the indicated days with 30 mM
glucose. (E) MnSOD expression was normalized to β-actin levels and the average of two
separate experiments is expressed as a fold control.
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Figure 8. Acute Hyperglycemia Increased MnSOD Activity but not Superoxide Production
(A) SCs were incubated with 5.5 mM or 30 mM glucose for the indicated time and a heavy
mitochondrial fraction was isolated. MnSOD activity was determined after a 30 min
preincubation with 2 mM NaCN to inhibit residual Cu/Zn SOD activity and results are the
mean ± SEM from three separate experiments. Asterisks indicate p < 0.05 compared to control.
(B) SCs were incubated with 5.5 mM or 30 mM glucose for the indicated time and cellular
superoxide levels were determined after the addition of 3 µM dihydroethidine. Results are the
mean of four experiments perform with 8 replicates each and are expressed as a percent of
control. (C) SCs were incubated with 5.5 mM or 30 mM glucose for 6 days, treated with
MitoSox Red and MitoTracker Green and mitochondrial levels of superoxide were visualized
by confocal microscopy. Incubation with Antimycin A served as a positive control for
mitochondrial superoxide generation. (D) Quantitative image analysis of superoxide levels.
Results are from a representative experiment performed twice and are the mean ± SEM from
at least 200 cells per treatment. Asterisk indicates p< 0.05 versus low and high glucose
treatments.
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